Publications by authors named "Mario N Laco"

Claim this Profile
M
Mitochondrial and redox modifications in early stages of Huntington's disease.
Carla Lopes, I Luísa Ferreira, Carina Maranga, Margarida Beatriz, Sandra I Mota

Redox Biol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinically Relevant Variants Causing KCNQ1-KCNE2 Gain-of-Function Affect the Ca Sensitivity of the Channel.
Christiane K Bauer, Tess Holling, Denise Horn, Mário Nôro Laço, Ebtesam Abdalla

Int J Mol Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A whole brain longitudinal study in the YAC128 mouse model of Huntington's disease shows distinct trajectories of neurochemical, structural connectivity and volumetric changes.
Lorena I Petrella, João M Castelhano, Mario Ribeiro, José V Sereno, Sónia I Gonçalves

Hum Mol Genet· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington's Disease Models.
Luana Naia, Tatiana R Rosenstock, Ana M Oliveira, Sofia I Oliveira-Sousa, Gladys L Caldeira

Mol Neurobiol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington's Disease human lymphoblasts.
Luana Naia, I Luísa Ferreira, Teresa Cunha-Oliveira, Ana I Duarte, Márcio Ribeiro

Mol Neurobiol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valosin-containing protein (VCP/p97) is an activator of wild-type ataxin-3.
Mário N Laço, Luisa Cortes, Sue M Travis, Henry L Paulson, A Cristina Rego

PLoS One· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compromised mitochondrial complex II in models of Machado-Joseph disease.
Mário N Laço, Catarina R Oliveira, Henry L Paulson, A Cristina Rego

Biochim Biophys Acta· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular turnover of the polyglutamine disease protein ataxin-3 is regulated by its catalytic activity.
Sokol V Todi, Mario N Laco, Brett J Winborn, Sue M Travis, Hsiang M Wen

J Biol Chem· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis